Crossmark

IFNGR1, IRF8 genetic polymorphisms modulate the susceptibility of non-tuberculous mycobacteria pulmonary disease and influence the patients’ treatment outcomes and immune status

Crossref DOI link: https://doi.org/10.1007/s00011-025-02071-y

Published Online: 2025-07-22

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheng, Li-ping

Liu, Zhi-bin

Wang, Lei

Cao, Jie

Qu, Qing-rong

Lou, Hai

Shen, Xiao-na

Yang, Juan

Yu, Yuanyuan

Zheng, Rui Juan

Sha, Wei

Sun, Qin
Funding

Funding for this research was provided by:

the National Key R&D Program of China (2023YFC2307300)

the Shanghai Scientific and Technological Innovation Project (22Y11900700)

Three Year Action Plan for the Construction of Shanghai Public Health System (GWVI-11.2-XD02)

Clinical Research Foundation of Shanghai Pulmonary Hospital (FKLY20012)
License Information

Text and Data Mining valid from 2025-07-22

Version of Record valid from 2025-07-22
More Information

Article History

Received: 15 February 2025

Accepted: 2 July 2025

First Online: 22 July 2025

Declarations

:

: The authors declare no competing interests.

: This study was performed in line with the principles of the Declaration of Helsinki. This study was approved by the Ethics Committees of Shanghai Pulmonary Hospital (Ethics No. fk19-001). Written informed consent was acquired from all patients.

: Not applicable.

Document is current

Any future updates will be listed below